#9650
Fasciola
hepatica IgG ELISA (Trematoda)
ELISA kit for the diagnosis of human fascioliasis
Lot 2306D (Expiry date: 14.10.2024)
Production date : 15.02.2023
Results of quality control 3 (after
12 months), date: 13.02.2024
No serum blank (average) : 0.119
Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
-0.002 |
0.000 |
0.004 |
-0.003 |
0.000 |
0 |
Negative control serum
(N° 9650-06) |
0.085 |
0.099 |
0.098 |
0.097 |
0.095 |
4 |
Weak positive serum
(N° 9650-07) |
0.398 |
0.423 |
0.413 |
0.463 |
0.425 |
18 |
Positive control
serum
(N° 9650-08) |
2.263 |
2.387 |
2.347 |
2.493 |
2.373 |
100 |
Validation criteria:
|
Criterion |
Measure |
Valid |
Absorbance of positive serum 9650-08 |
> 1.200 |
2.373 |
Yes |
Absorbance of weak positive serum 9650-07, as % of positive serum |
> 8 % |
18 % |
Yes |
Absorbance of negative serum 9650-06, as % of positive serum |
< 8 % |
4 % |
Yes |
Absorbance of no serum blank |
< 0.350 |
0.119 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bātiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|